2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine

BACKGROUND: NasoVAX is a replication-deficient adenovirus-based vaccine designed to express influenza hemagglutinin in nasal epithelial cells when given as a nasal spray. In preclinical studies, NasoVAX was associated with divergent strain protection. Prior preclinical and clinical studies with the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Forum Infect Dis
Autori principali: Tasker, Sybil, Krishnan, Vyjayanthi, Bart, Stephan, Suyundikov, Anvar, Booth, Peta-Gay, Wight O’Rourke, Anna, Zhang, Jianfeng, Georges, Bertrand, Roberts, Scot
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253025/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy209.162
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi